| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.23 | 9e-07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.23 | 6e-06 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.22 | 8e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.21 | 8e-06 |